COO

Cooper Companies (The)
D

COO

95.340
USD
2.05
(2.20%)
Market Closed
Volume
53,141
EPS
4
Div Yield
-
P/E
49
Market Cap
19,028,207,563
Related Instruments
    ABT
    ABT
    3.320
    (2.93%)
    116.810 USD
    B
    BAX
    0.520
    (1.68%)
    31.490 USD
    BDX
    BDX
    2.920
    (1.23%)
    240.260 USD
    ILMN
    ILMN
    4.680
    (3.43%)
    141.305 USD
    MDT
    MDT
    0.310
    (0.35%)
    88.400 USD
    SYK
    SYK
    12.46
    (3.25%)
    395.88 USD
    TMO
    TMO
    13.24
    (2.36%)
    572.91 USD
    X
    XRAY
    0.195
    (1.04%)
    18.960 USD
    ZBH
    ZBH
    1.040
    (0.95%)
    110.600 USD
    More
News

Title: Cooper Companies (The)

Sector: Healthcare
Industry: Medical Instruments & Supplies
CooperCompanies is one of the largest eyecare companies in the us. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the us contact lens market. CooperSurgical,founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the us, and controls 17% of the us IUD market.
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.